Genentech Wins FDA Approval for First Adjuvant Therapy for ALK-Positive, Early NSCLC 4/19/2024

Sanofi Cuts Jobs in US Vaccines Division as Part of Restructuring 4/19/2024

J&J, Other Q1 Financials Beg the Queston: What Does It Mean to Miss Expectations? 4/19/2024

Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies 4/19/2024

Weight-Loss Drug Startup Metsera Launches with $290M, Looks to Tap Lucrative Obesity Market 4/18/2024

Intra-Cellular Looks to Raise $500M in Public Offering Following Phase III MDD Win 4/18/2024

Cerevel Gets Phase III Parkinson’s Win on Heels of $8.7B AbbVie Acquisition 4/18/2024

Most Doses of Lilly’s Zepbound and Mounjaro in Short Supply Through Q2: FDA 4/18/2024

Teva, Alvotech Secure FDA Approval for Stelara Biosimilar with Early 2025 Launch 4/18/2024

Roche’s Ocrevus Achieves Near-Complete Reduction of Relapse, Lesions in MS 4/18/2024

Bioversity Program Preps Grads for Early-Career Life Science Roles 4/18/2024

How to Deal With Layoff-Related Stress 4/18/2024

Career Coach: How to Look Professional in Virtual Meetings 4/18/2024

5 Top Companies Hiring Oncology Jobs 4/18/2024

Lilly Eyes Zepbound Label Expansion After Clearing Phase III Sleep Apnea Study 4/17/2024

Sage Axes Parkinson’s Program for Dalzanemdor After Phase II Flop 4/17/2024

Amylyx Sheds More Light on Relyvrio’s Late-Stage Trial Failure in ALS 4/17/2024

Amylyx at a Crossroads: Can the Company Overcome the Loss of Relyvrio? 4/17/2024

Arvinas Strikes Deals With Pfizer, Novartis to Compete in Protein Degrader Space 4/17/2024

Top Q1 Series A Investments Highlight VC Rebound in Biopharma 4/17/2024